Havens Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Havens Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-81,300	Closed	-$7.88M	–	38
2019 Q3	$7.88M	Buy	81,300 +27,600	+51%	+$2.76M	7.17%	6
2019 Q2	$5.5M	Buy	53,700 +28,700	+115%	+$3.1M	3.87%	9
2019 Q1	$2.85M	Buy	+25,000	New	+$1.84M	2.76%	15

Havens Advisors's ONCE Position: Q4 2019 in Review

Havens Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 81,300 shares — an estimated $7.88M sold.

Havens Advisors first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $7.88M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Havens Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Havens Advisors sold 81,300 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $7.88M.
Havens Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Havens Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $7.88M in Q3 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Havens Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.